CPP, an NMDA-receptor antagonist, blocks 4-aminopyridine-induced spreading depression episodes but not epileptiform activity in immature rat hippocampal slices

Neurosci Lett. 1992 Jan 20;135(1):139-43. doi: 10.1016/0304-3940(92)90155-z.

Abstract

Spontaneous episodes of spreading depression (SD) were observed in the CA3 subfield of immature or young (2-30 days postnatally) hippocampal slices perfused with medium containing 4-aminopyridine (4-AP, 50 microM). SD appeared in 34% of the hippocampal slices examined and was more frequently observed in slices obtained from 11 to 20-day-old animals. SD studied with extracellular field potential recordings consisted of large amplitude (18.7 +/- 1.1 mV, mean +/- S.E.M.) negative DC shifts that lasted 30-250 s. Unlike the epileptiform activity that was concomitantly seen during 4-AP application, SD was blocked by the NMDA receptor antagonist 3-((RS)-2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (CPP, 2-10 microM). In contrast, 6-cyano-7-nitro-quinoxaline-2,3-dione (CNQX, 5 microM), a non-NMDA-type receptor antagonist, blocked the epileptiform activity but only increased the interval between SD episodes. These results demonstrate that immature hippocampal tissue is susceptible to SD episodes, when perfused with 4-AP-containing medium, and that the occurrence of these episodes presumably depends on the activation of the NMDA receptor. In addition these findings indicate that SD shows a sensitivity to excitatory amino acid receptor antagonists that differs from that of the epileptiform activity recorded simultaneously.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / antagonists & inhibitors
  • 4-Aminopyridine / pharmacology*
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • Aging
  • Animals
  • Animals, Newborn
  • Anticonvulsants / pharmacology*
  • Dendrites / drug effects
  • Dendrites / physiology
  • Epilepsy / physiopathology
  • Evoked Potentials / drug effects
  • Hippocampus / drug effects
  • Hippocampus / growth & development
  • Hippocampus / physiology*
  • In Vitro Techniques
  • Membrane Potentials / drug effects
  • Models, Biological
  • Piperazines / pharmacology*
  • Pyramidal Tracts / drug effects
  • Pyramidal Tracts / growth & development
  • Pyramidal Tracts / physiology*
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*

Substances

  • Anticonvulsants
  • Piperazines
  • Quinoxalines
  • Receptors, N-Methyl-D-Aspartate
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
  • 4-Aminopyridine